#9650
Fasciola
hepatica IgG ELISA (Trematoda)
ELISA kit for the diagnosis of human fascioliasis
Lot 2306D (Expiry date: 14.10.2024)
Production date : 15.02.2023
Results of quality control 4 (after
20 months), date: 15.10.2024
No serum blank (average) : 0.137
| Sample |
Absorbances of individual wells after blank reduction |
Average |
% pos. |
No serum blank
|
-0.006 |
0.001 |
-0.011 |
0.015 |
0.000 |
0 |
Negative control serum
(N° 9650-06) |
0.090 |
0.081 |
0.087 |
0.085 |
0.086 |
3 |
Weak positive serum
(N° 9650-07) |
0.422 |
0.463 |
0.398 |
0.449 |
0.433 |
16 |
Positive control
serum
(N° 9650-08) |
2.367 |
2.880 |
2.487 |
2.844 |
2.645 |
100 |
Validation criteria:
| |
Criterion |
Measure |
Valid |
| Absorbance of positive serum 9650-08 |
> 1.200 |
2.645 |
Yes |
| Absorbance of weak positive serum 9650-07, as % of positive serum |
> 8 % |
16 % |
Yes |
| Absorbance of negative serum 9650-06, as % of positive serum |
< 8 % |
3 % |
Yes |
| Absorbance of no serum blank |
< 0.350 |
0.137 |
Yes |
Comments:
Good for use.
Bordier Affinity Products SA, Chatanerie 2,
Bātiment Biokema,
CH-1023 Crissier, Switzerland
Phone: + 41 21 633 31 67. Fax: +
41 21 633 31 78. Email: cb(at)bordier.ch
|